Article Information
History
- August 24, 2023.
Article Versions
- You are currently viewing Version 1 of this article (August 24, 2023 - 09:07).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Dragos C. Gruia1,3,
- William Trender1,
- Peter Hellyer2,
- Soma Banerjee1,3,
- Joseph Kwan1,3,
- Henrik Zetterberg4,5,6,7,8,9,
- Adam Hampshire1 and
- Fatemeh Geranmayeh1,3,*
- 1Department of Brain Sciences, Imperial College London, London, W12 0NN, UK
- 2Centre for Neuroimaging Sciences, IoPPN, King’s College London. SE5 8AF, London, UK
- 3Imperial College NHS Healthcare Trust, London W6 8RF, UK
- 4Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
- 5Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- 6Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
- 7UK Dementia Research Institute at UCL, London, UK
- 8Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China
- 9Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
- ↵*Corresponding author: Dr Fatemeh Geranmayeh Clinical Language and Cognition group. Department of Brain Sciences. Imperial College London. London W12 0NN. UK fatemeh.geranmayeh00{at}imperial.ac.uk